Table 2.

Studies evaluating the effect of pre-alloHCT geriatric assessment on post-alloHCT outcomes in older patients

ReferencesPatientsGeriatric measures associated with OSGeriatric measures associated with NRM/TRM
Muffly et al34  n = 203, age 50-73 y Functional status (IADL), comorbidity (HCTCI), degree of inflammation (CRP), gait speed (15 ft), mental health (SF36-MCS; multivariate analysis). Functional status (IADL), comorbidity (HCTCI), degree of inflammation (CRP). 
Huang et al37  n = 148, age 50-76 y Functional status (IADL, MOS-PH) Functional status (MOS-PH) 
Deschler et al38  n = 106, age 60-78 y Gait speed (TUG test), fatigue. Comorbidity (HCTCI) 
ReferencesPatientsGeriatric measures associated with OSGeriatric measures associated with NRM/TRM
Muffly et al34  n = 203, age 50-73 y Functional status (IADL), comorbidity (HCTCI), degree of inflammation (CRP), gait speed (15 ft), mental health (SF36-MCS; multivariate analysis). Functional status (IADL), comorbidity (HCTCI), degree of inflammation (CRP). 
Huang et al37  n = 148, age 50-76 y Functional status (IADL, MOS-PH) Functional status (MOS-PH) 
Deschler et al38  n = 106, age 60-78 y Gait speed (TUG test), fatigue. Comorbidity (HCTCI) 

CRP, C-reactive protein; MOS-PH, Medical Outcomes Study Physical Health scale; SF36-MCS, Mental Component Summary of the Medical Outcomes Short Form-36; TRM, treatment-related mortality; TUG, Timed Up and Go.

Close Modal

or Create an Account

Close Modal
Close Modal